- PLATFORM LOGINS
- |
- CONTACT
- Request a Demo
-
Vitality® GlowCap®, an industry leading smart pill bottle, has been proven to be effective for improving medication adherence
Vitality GlowCap is a smart pill bottle that offers automated visual and audible alerts during scheduled medication dosage windows that signal when it is time for the user to take his or her medications. With the new Vitality Mobile app, users can link their mobile device to a Vitality GlowCap to view and track their medication adherence in near-real time. Additionally, users may give their clinicians, care managers and family members access to their adherence information, allowing for buddy reminders and social support.
“Medication nonadherence is a major public health concern that not only
affects patient outcomes, but is also costing the overall healthcare
industry
In a peer-reviewed study
conducted with
In addition to providing patients an easy and sustainable way to manage their own medications, the Vitality medication adherence system, comprised of GlowCap and Vitality Mobile, is also useful for hospitals and health systems, pharmacies, accountable care organizations, health insurers, wellness providers and clinical trial sponsors. Specifically, Vitality Mobile can assist pharmaceutical companies, contract research organizations and hospitals in tracking the frequency that their participants are taking medication – which is required for successful studies.
Cautionary Note Concerning Forward-Looking Statements
This press release contains forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995,
including, among others, statements regarding the capabilities and
anticipated utility of our GPS Cancer, including predicting patient
response and resistance to therapeutics, enabling diagnoses by
physicians and accelerating efforts to bring novel combinations of
therapeutic agents to cancer patients. Forward-looking statements are
subject to numerous risks and uncertainties that could cause actual
results to differ materially from currently anticipated results. Factors
that may cause future results to differ materially from management’s
current expectations include, among other things, that GPS Cancer may
not perform as anticipated, that sufficient physicians may not adopt GPS
Cancer to assist their diagnoses or that healthcare payers may not
provide reimbursement for GPS Cancer as expected. Our business is
subject to numerous additional risks and uncertainties, including, among
others, risks relating to market acceptance of our products; our ability
to successfully launch new products and applications; competition; our
sales, marketing and distribution capabilities; our planned sales,
marketing, and research and development activities; unanticipated
increases in costs or expenses; and risks associated with international
operations. Information on these and additional risks, uncertainties,
and other information affecting our business and operating results can
be found in our existing and future filings with the
About
1 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3934668/
View source version on businesswire.com: http://www.businesswire.com/news/home/20171025005299/en/
NANTHEALTH MEDIA CONTACT
jhodson@nantworks.com
Source: